Simulations Plus Inc.

NASDAQ:SLP

17.75

-0.61 (-3.32%)

4:20:00 PM EDT: $17.75 0.00 (0.00%)

Market Cap (Intraday)	345.12M
Current PE	47.54
Forward PE	18.88
2yr Forward PE	16.59

See more stats

Estimates Current Quarter

Revenue	$22.79 Million
Adjusted EPS	$0.28

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Simulations Plus Inc. Stock, NASDAQ:SLP

800 Park Offices Drive, Suite 401, Durham, North Carolina 27709

United States of America

Phone: +1.661.723.7723

Number of Employees: 247

http://www.simulations-plus.com

Description

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.